Company intelligence / Profile preview
Virchow Biotech Private Limited
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Commercial
Overview
Virchow Biotech has successfully developed several first-in-class or best-in-class biogeneric therapeutics such as Healace (rh PDGF-BB) for chronic wounds and Osteotide (teriparatide) for osteoporosis. These are marketed in India by major pharma partners. The company maintains a robust pipeline across multiple therapeutic areas with both commercialized products and candidates in development stages.
- Therapeutic areas
- OncologyEndocrinologyHematologyDermatologyRheumatologyOphthalmology
- Modalities
- Biogenericsrecombinant proteinsnon-recombinant biomoleculesplasma and sera productswound management solutionsorthopedics productsprobiotics
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Virchow Biotech Private Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virchow Biotech Private Limited.